New pain relief combo may improve recovery in oral cancer surgery
NCT ID NCT07401641
First seen Feb 13, 2026 · Last updated May 14, 2026 · Updated 14 times
Summary
This study tests two different painkiller combinations (dezocine vs. nalbuphine, both with sufentanil) in 60 adults undergoing oral cancer surgery with flap reconstruction. The goal is to find which provides better pain control, fewer side effects like nausea, and helps the surgical flap heal better. Participants are randomly assigned to one of the two groups, and pain levels are measured at 2, 24, and 48 hours after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN MANAGEMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Anesthesiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen Universit
RECRUITINGGuangzhou, Guangdong, 510000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.